SILVERTON HOSPITAL
1. Target Overview & Investment Thesis
SILVERTON HOSPITAL is a 29-bed safety-net/medicaid heavy in MARION, OR with $118.4M in net patient revenue and a -16.1% operating margin. The hospital serves a payer mix of 9.8% Medicare, 30.0% Medicaid, and 60.2% commercial.
Thesis: Turnaround. Our ML models identify $8.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -16.1% to -8.7% (+736bps).
| Net Revenue HCRIS | $118.4M |
| Current EBITDA COMPUTED | $-19.1M |
| Operating Margin COMPUTED | -16.1% |
| Occupancy HCRIS | 72.7% |
| Revenue / Bed COMPUTED | $4.1M |
| Net-to-Gross HCRIS | 44.6% |
| Distress Probability ML | 45.7% |
2. Market Context & Competitive Position
OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of -16.1% places it below the state median. Among 33 size-comparable peers (14-58 beds), the median margin is -6.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (14-58), prioritizing same-state peers. 33 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SILVERTON HOSPITAL (Target) | OR | 29 | $118.4M | -16.1% |
| GOOD SHEPHERD MEDICAL CENTER | OR | 25 | $177.5M | 5.3% |
| COLUMBIA MEMORIAL HOSPITAL | OR | 25 | $165.9M | 5.2% |
| SAMARITAN LEBANON COMM HOSPITA | OR | 25 | $157.9M | 3.9% |
| PROVIDENCE NEWBERG MEDICAL CEN | OR | 40 | $151.5M | 10.0% |
| SAMARITAN PACIFIC COMM HOSPITA | OR | 25 | $141.7M | 3.7% |
| GRANDE RONDE HOSPITAL | OR | 25 | $134.8M | -4.1% |
| PROVIDENCE MILWAUKIE HOSPITAL | OR | 40 | $128.8M | -9.6% |
| MID-COLUMBIA MEDICAL CENTER | OR | 44 | $123.2M | -20.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $76K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-19.1M |
| + RCM Uplift | +$8.7M |
| Pro Forma EBITDA | $-10.4M |
| Current Margin | -16.1% |
| Pro Forma Margin | -8.7% |
| WC Released (1x) | $4.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-29.3M | $-38.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-29.3M | $-52.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-26.4M | $-32.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-26.4M | $-43.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-32.3M | $-72.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-32.3M | $-90.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (30.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 33 hospitals with 14-58 beds
- Same-state prioritization (n=34)
- Comp margins: P25=-13.9% / P50=-6.1% / P75=3.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.